UK HOSPITALIZATIONS DUE TO STROKE IN PROSTATE CANCER PATIENTS TREATED WITH ANDROGEN DEPRIVATION THERAPY (ADT)

被引：0
|
作者：
Jefferies, Edward
Bahl, Amit
Hounsome, Luke
Eylert, Maike
Verne, Julia
Persad, Raj
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.02.1035
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
937
引用
收藏
页码：E381 / E382
页数：2
相关论文
共 50 条
  • [41] Reversibility of androgen deprivation therapy in patients with prostate cancer
    Fridmans, A
    Chertin, B
    Koulikov, D
    Lindenberg, T
    Gelber, H
    Leiter, C
    Farkas, A
    Spitz, IM
    JOURNAL OF UROLOGY, 2005, 173 (03): : 784 - 789
  • [42] Perceptions on coordination of care in prostate cancer patients treated with radiotherapy (RT) and androgen deprivation therapy (ADT): Implications for survivorship care planning.
    Holmes, Jordan A.
    Anderson, Roger F.
    Hoffman, Leroy G.
    Showalter, Timothy Norman
    Kasibhatla, Mohit S.
    Collins, Sean P.
    Papagikos, Michael A.
    Barbosa, Brittney Diane
    Stravers, Lori
    Mahbooba, Zahra
    Wang, Andrew
    Chen, Ronald C.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [43] SIGNIFICANT AGE DEPENDENCE OF TESTOSTERONE RECOVERY AFTER ANDROGEN DEPRIVATION (ADT) IN PROSTATE CANCER PATIENTS TREATED WITH CURATIVE RADIATION
    Probst, Carlos Mendez
    Carreno, Alfonso Fernandez
    Erdeljan, Petar
    Sener, Alp
    Vanjecek, Maaike
    Cadieux, Peter
    Razvi, Hassan
    JOURNAL OF UROLOGY, 2010, 183 (04): : E761 - E762
  • [44] Does Use of Androgen Deprivation Therapy (ADT) in Men with Prostate Cancer Increase the Risk of Sarcopenia?
    Owen, Patrick J.
    Daly, Robin M.
    Dalla Via, Jack
    Mundell, Niamh L.
    Livingston, Patricia M.
    Rantalainen, Timo
    Fraser, Steve F.
    CALCIFIED TISSUE INTERNATIONAL, 2019, 105 (04) : 403 - 411
  • [45] Denosumab for prevention of fractures in men receiving androgen deprivation therapy (ADT) for prostate cancer (PC)
    Saad, F.
    Smith, M. R.
    Egerdie, B.
    Tammela, T. L.
    Feldman, R. A.
    Heracek, J.
    Szwedowski, M.
    Ke, C.
    Leder, B.
    Goessl, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] MR imaging biomarkers profiles in patients with prostate cancer treated with androgen deprivation therapy
    Sanchez Iglesias, A. L.
    Morillo Macias, V.
    Nogue Infante, A.
    Domingo, M.
    Aznar, V.
    Yebana, R.
    Puerto Frances, C.
    Fuster-Matanzo, A.
    Plaza Ortega, P.
    Bellvis Bataller, F.
    Soria, R. Muelas
    Alberich Bayarri, A.
    Ferrer Albiach, C.
    ANNALS OF ONCOLOGY, 2023, 34 : S245 - S246
  • [47] A Review on the Effects of Androgen Deprivation Therapy (ADT) on Bone Health Status in Men with Prostate Cancer
    Mohamad, Nur-Vaizura
    Soelaiman, Ima-Nirwana
    Chin, Kok-Yong
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2017, 17 (04) : 276 - 284
  • [48] Does Use of Androgen Deprivation Therapy (ADT) in Men with Prostate Cancer Increase the Risk of Sarcopenia?
    Patrick J. Owen
    Robin M. Daly
    Jack Dalla Via
    Niamh L. Mundell
    Patricia M. Livingston
    Timo Rantalainen
    Steve F. Fraser
    Calcified Tissue International, 2019, 105 : 403 - 411
  • [49] Patients with prostate cancer treated by androgen deprivation therapy: Impact of adapted physical activity
    Veni, T.
    Leroy, V.
    Pradere, B.
    Rebillard, A.
    Mathieu, R.
    PROGRES EN UROLOGIE, 2019, 29 (15): : 912 - 916
  • [50] Changes in bone mineral density in patients with prostate cancer treated with androgen deprivation therapy
    Bernat, MM
    Pasini, J
    Marekovic, Z
    COLLEGIUM ANTROPOLOGICUM, 2005, 29 (02) : 589 - 591
12345